Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazuo Mikami is active.

Publication


Featured researches published by Kazuo Mikami.


International Journal of Urology | 2009

Incidence of inguinal hernia after prostate surgery: Open radical retropubic prostatectomy versus open simple prostatectomy versus transurethral resection of the prostate

Nobuyuki Sekita; Hiroyoshi Suzuki; Shuichi Kamijima; Kensei Chin; Masaaki Fujimura; Kazuo Mikami; Tomohiko Ichikawa

Our objective was to determine the incidence of inguinal hernia (IH) after surgery for prostatic diseases. Medical records of 395 patients who underwent radical retropubic prostatectomy (RRP; n = 155), open simple prostatectomy (OP; n = 35), or transurethral resection of the prostate (TURP; n = 205) at the Chibaken Saiseikai Narashino Hospital from April 2000 to March 2007 were retrospectively evaluated. The incidence of IH was 23.9% in the RRP group, 18.9% in the OP group, and 2% in the TURP group. Overall, 91.9% in the RRP and 83.3% in the OP group developed an IH within 2 years postoperatively. The laterality of IH after open surgery was mainly on the right side. Subclinical IH were seen in 25% of RRP cases. The existence of subclinical IH was the only significant risk factor for postoperative IH in this analysis. Furthermore, OP and RRP procedures significantly increased the risk of postoperative IH compared with TURP. The hernia‐free ratios were significantly lower after RRP and OP than after TURP (vs RRP: P < 0.001; vs OP: P < 0.001). Our findings confirm that a lower abdominal incision itself is associated with postoperative IH in patients undergoing prostate surgery. Attention must be paid to pre‐existing subclinical IH through careful preoperative assessment. Patients should be followed for more than 2 years due to the high incidence of postoperative IH.


International Journal of Urology | 2006

Clinical impact of tamsulosin on generic and symptom‐specific quality of life for benign prostatic hyperplasia patients: Using international prostate symptom score and Rand Medical Outcomes Study 36‐item Health Survey

Hiroyoshi Suzuki; Masashi Yano; Yusuke Awa; Hiroomi Nakatsu; Ken-ichi Egoshi; Kazuo Mikami; Sho Ota; Tatsuya Okano; Satoru Hamano; Takemasa Ohki; Yuzo Furuya; Tomohiko Ichikawa

Aim: To examine the efficiency of α1‐blocker treatment on disease‐specific and generic quality of life (QOL) in men with clinically diagnosed benign prostatic hyperplasia (BPH), the improvement of QOL scores with International prostate symptom score (I‐PSS) and Rand Medical Outcomes Study 36‐item Health Survey (SF‐36) was prospectively analyzed.


International Journal of Urology | 2003

Usefulness of diagnostic imaging in primary hyperparathyroidism

Kazuya Sekiyama; Koichiro Akakura; Kazuo Mikami; Ken-ichi Mizoguchi; Toyofusa Tobe; Koichi Nakano; Tsutomu Numata; Akiyoshi Konno; Haruo Ito

Background : In patients with primary hyperparathyroidism, prevention of urinary stone recurrence can be achieved by surgical removal of the enlarged parathyroid gland. To ensure the efficacy of surgery for primary hyperparathyroidism, preoperative localization of the enlarged gland is important. In the present study, usefulness of diagnostic imaging for localization of the enlarged gland was investigated in primary hyperparathyroidism.


International Journal of Urology | 2009

External validation and head‐to‐head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets

Takanobu Utsumi; Koji Kawamura; Hiroyoshi Suzuki; Naoto Kamiya; Takashi Imamoto; Junichiro Miura; Takeshi Ueda; Masayuki Maruoka; Nobuyuki Sekita; Kazuo Mikami; Tomohiko Ichikawa

The objective of this study was to perform external validation of a previously developed prostate biopsy nomogram (the CHIBA nomogram) and to compare it with previously published nomograms developed in Japanese and overseas populations. Two different cohorts of patients were used: one from the Chiba Cancer Center (n = 392) in which transperineal 16‐core biopsy was performed, and another from Chibaken Saiseikai Narashino Hospital (n = 269) in which transrectal 16‐core biopsy was carried out. All patients were Japanese men with serum prostate‐specific antigen levels less than 10 ng/mL. The predictive accuracy of our CHIBA nomogram and of four other published nomograms (Finnes sextant biopsy‐based logistic regression model, Karakiewiczs sextant biopsy‐based nomogram, Chuns 10‐core biopsy‐based nomogram and Kawakamis three‐dimensional biopsy‐based nomogram) was quantified based on area under the curve derived from receiver operating characteristic curves. Head‐to‐head comparison of area under the curve values demonstrated that our nomogram was significantly more accurate than all other models except Chuns (P = 0.012 vs Finnes, P = 0.000 vs Karakiewiczs, and P = 0.003 vs Kawakamis). Our nomogram appears to be more useful for the Japanese population than Western models. Moreover, external validation demonstrates that its predictive accuracy does not vary according to biopsy approach. This is the first report to demonstrate that the predictive accuracy of a nomogram is independent from the biopsy method.


International Journal of Urology | 2002

Detection and identification of oxalate-degrading bacteria in human feces

Takaomi Kodama; Koichiro Akakura; Kazuo Mikami; Haruo Ito

Background : Oxalate is detoxified (catabolized) via the action of two enzymatic proteins, formyl coenzyme A transferase (encoded by the frc gene) and oxalyl coenzyme A decarboxylase (encoded by the oxc gene), contained in the cytosol of Oxalobacter formigenes that colonizes the human intestinal tract. It is speculated that oxalate‐degrading bacteria decrease oxalate absorption from the intestines and their absence in the gastrointestinal tract correlates with the formation of calcium‐oxalate urolithiasis.


International Journal of Urology | 2010

Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A prospective study

Akira Komiya; Hiroyoshi Suzuki; Yusuke Awa; Ken-ichi Egoshi; Tetsuro Onishi; Hiroomi Nakatsu; Takemasa Ohki; Kazuo Mikami; Naohide Sato; Kazuhiro Araki; Sho Ota; Yukio Naya; Tomohiko Ichikawa

Objectives:  To investigate the benefit of α1‐adrenoceptor antagonist naftopidil on the quality of life (QOL) of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH/LUTS).


Biomedicine & Pharmacotherapy | 2000

Laparoscopic adrenalectomy for functioning adrenal tumors: clinical experiences with 38 cases and comparison with open adrenalectomy.

Tomohiko Ichikawa; Kazuo Mikami; Akira Komiya; Hiroyoshi Suzuki; Akiyuki Shimizu; Koichiro Akakura; Tatsuo Igarashi; Haruo Ito

We reviewed 38 cases of transperitoneal or retroperitoneal laparoscopic adrenalectomy for unilateral benign functioning adrenal tumors and compared the results with those of a recent series of 36 patients undergoing an open adrenalectomy. The tumors were removed successfully in all but two cases with laparoscopy that required open laparotomy. In the other 36 cases of the laparoscopy group, mean operative time and blood loss were 225 minutes and 138 mL, respectively. Mean operative time was significantly longer for the laparoscopy group (122 minutes for open surgery: P < 0.0001), whereas mean blood loss of the laparoscopy group was almost equal to that of the open surgery group. Mean intervals to first ambulation and oral intake, and postoperative hospital stay of the laparoscopy group were significantly less than those of the open surgery group (1.4 vs 2.0 days: P = 0.014; 1.8 vs 2.9 days: P < 0.0001; and 8.5 vs 12.9 days: P < 0.0001, respectively). We conclude that laparoscopic adrenalectomy is equally effective and less invasive than open adrenalectomy. and that it should be considered as the first-choice therapy for benign adrenal tumors.


Urology | 2000

Gasless, hand-assisted retroperitoneoscopic nephroureterectomy for urothelial cancer of the upper urinary tract

Tatsuo Igarashi; Toyofusa Tobe; Kazuo Mikami; Hiroyoshi Suzuki; Tomohiko Ichikawa; Haruo Ito

We report our initial experiences with gasless, hand-assisted retroperitoneoscopic nephroureterectomy for the treatment of urothelial cancer of the upper urinary tract. One hand was inserted by way of the small incision made in the lower abdomen. This method provides easy maneuverability and an acceptable operative time without opening the upper urinary tract.


International Journal of Urology | 2003

Annual changes of the incidence and clinical characteristics of magnesium ammonium phosphate urinary stones

Takahide Ogata; Koichiro Akakura; Kenichi Mizoguchi; Kazuo Mikami; Kuniyoshi Nozumi; Haruo Ito

Background: Magnesium ammonium phosphate (MAP) urinary stones account for the majority of staghorn stones and frequently cause a non‐functioning kidney. In the present study, we examined the annual changes of the number and clinical characteristics of MAP stones.


European Urology | 2002

Clinical Characteristics of Prostate Cancer in Elderly Japanese Patients 80 Years of Age or Older

Hiroyoshi Suzuki; Koichiro Akakura; Takeshi Ueda; Kazuo Mikami; Toyofusa Tobe; Akira Komiya; Tomohiko Ichikawa; Tatsuo Igarashi; Haruo Ito

OBJECTIVE Prostate adenocarcinoma is predominantly a disease of elderly men. This study retrospectively examined prostate adenocarcinoma in Japanese patients 80 years of age or older to determine the natural history and prognosis of this malignancy in the elderly population. METHODS The medical records of 593 patients were reviewed, with respect to age, histologic grade, clinical and pathological stage, treatment modality and clinical outcome. A variety of possible clinical factors were compared between patient groups > or = 80 and < 80 years old. RESULTS No significant difference in clinical stage, tumor grade, and performance status (PS) was found between two age groups of patients with prostate cancer. A significant stage migration between pre-PSA era and PSA era was found only in the group < 80 years old. In the series of stage D2 cancer patients, while there was no significant difference in cause-specific and progression-free survival rates between the two groups, the younger group < 80 years old had a better marker response at 3 months from the start of endocrine therapy compared with the older group (P = 0.0048, chi2 analysis). CONCLUSION These data suggest that patients > or = 80 years with prostate cancer present with similar histologic grade and disease stage as younger patients, although the younger group with stage D2 had a better marker response to endocrine therapy.

Collaboration


Dive into the Kazuo Mikami's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge